MEX3A copy number amplification occurred in 10% of ovarian cancer samples in TCGA cohort (Fig. 1H), and MEX3A mRNA expression increased in patients with amplification (Fig. 1I). This evidence concerns the gene MEX3A and ovarian carcinoma.